NYSE: GSK
Gsk PLC Earnings Dates, Reports, Calls

Gsk earnings were $5.8B for the trailing 12 months ending Sep 30, 2026, with -21.3% growth year over year. The latest GSK earnings report on Sep 30, 2026 announced Q3 2026 earnings of $2.0B, up 252.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GSK reported annual earnings of $7.7B, with 140% growth.

GSK past earnings growth

How has GSK's earnings growth performed historically?

Company
-21.3%
Industry
39.98%
Market
91.78%
GSK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GSK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
GSK's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

GSK earnings history

Current Revenue
$44.5B
Current Earnings
$5.8B
Current Profit Margin
13%
GSK's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

GSK Return on Equity

Current Company
24.5%
Current Industry
12.7%
Current Market
35.8%
GSK's Return on Equity (24.5%)... subscribe to Premium to read more.
High Return on Equity Performance

GSK Return on Assets

Current Company
6.8%
Current Industry
10.3%
GSK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GSK announces earnings.

GSK Return on Capital Employed

Current Company
11.12%
Current Industry
18.2%
GSK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GSK vs General Drug Manufacturer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GSK$11.70B$5.79B-0.21%$2.89
SNY$14.52B$4.56B-7.24%$1.90
BMY$14.12B$9.24B+10.04%$4.53
BIIB$1.33B$347.50M-25.80%$2.36
PFE$10.72B$4.03B-27.15%$0.71

Gsk Earnings Reports & History FAQ

What were Gsk's earnings last quarter?

On GSK's earnings call on Oct 28, 2026, Gsk (NYSE: GSK) reported Q3 2026 earnings per share (EPS) of $1.02, up 24.31% year over year. Total GSK earnings for the quarter were $2.05 billion. In the same quarter last year, Gsk's earnings per share (EPS) was $1.35.

If you're new to stock investing, here's how to buy Gsk stock.

Is Gsk profitable or losing money?

As of the last Gsk earnings report, Gsk is currently profitable. Gsk's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $5.77 billion, a 22.27% decrease year over year.

What was GSK's earnings growth in the past year?

As of Gsk's earnings date in Oct 28, 2026, Gsk's earnings has grown -21.3% year over year. This is 61.28 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 39.98%. GSK earnings in the past year totalled $5.79 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.